Literature DB >> 26116737

MicroRNA in Cancer and Cachexia--A Mini-Review.

Mario Acunzo1, Carlo M Croce1.   

Abstract

MicroRNAs (miRNAs) are short noncoding RNAs with a length of approximately 22 nucleotides that are involved in posttranscriptional regulation of gene expression. miRNAs cover an important role in all biological processes, and aberrant miRNA expression is commonly associated with cancer. Recent discoveries have associated the involvement of miRNA in an increasingly large number of biological processes, including cachexia. The cachexia syndrome is a debilitating state of cancer that is, at least in part, associated with apoptosis. The mechanism through which tumors promote the characteristic distal loss of muscle and fat mass during the cachectic process is still not deeply investigated. In this review, we briefly describe the role of miRNAs in cancer development and cachexia.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cachexia; cancer; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26116737      PMCID: PMC4574551          DOI: 10.1093/infdis/jiv197

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

Review 1.  Apoptosis of skeletal muscles during development and disease.

Authors:  M Sandri; U Carraro
Journal:  Int J Biochem Cell Biol       Date:  1999-12       Impact factor: 5.085

2.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

Review 3.  Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Authors:  Alessandro Allegra; Andrea Alonci; Salvatore Campo; Giuseppa Penna; Annamaria Petrungaro; Demetrio Gerace; Caterina Musolino
Journal:  Int J Oncol       Date:  2012-10-01       Impact factor: 5.650

4.  A pancreatic islet-specific microRNA regulates insulin secretion.

Authors:  Matthew N Poy; Lena Eliasson; Jan Krutzfeldt; Satoru Kuwajima; Xiaosong Ma; Patrick E Macdonald; Sébastien Pfeffer; Thomas Tuschl; Nikolaus Rajewsky; Patrik Rorsman; Markus Stoffel
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

5.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.

Authors:  Muller Fabbri; Alessio Paone; Federica Calore; Roberta Galli; Eugenio Gaudio; Ramasamy Santhanam; Francesca Lovat; Paolo Fadda; Charlene Mao; Gerard J Nuovo; Nicola Zanesi; Melissa Crawford; Gulcin H Ozer; Dorothee Wernicke; Hansjuerg Alder; Michael A Caligiuri; Patrick Nana-Sinkam; Danilo Perrotti; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

7.  miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Authors:  Michela Garofalo; Gianpiero Di Leva; Giulia Romano; Gerard Nuovo; Sung-Suk Suh; Apollinaire Ngankeu; Cristian Taccioli; Flavia Pichiorri; Hansjuerg Alder; Paola Secchiero; Pierluigi Gasparini; Arianna Gonelli; Stefan Costinean; Mario Acunzo; Gerolama Condorelli; Carlo Maria Croce
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

8.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

9.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

Review 10.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

View more
  28 in total

1.  MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression.

Authors:  Lei Hongwei; Li Juan; Xu Xiaoying; Fan Zhijun
Journal:  Cytotechnology       Date:  2022-06-06       Impact factor: 2.040

2.  MicroRNA-496 suppresses tumor cell proliferation by targeting BDNF in osteosarcoma.

Authors:  Jing Ye; Wei Xie; Yunzhou Zuo; Guangwu Jing; Jie Tong
Journal:  Exp Ther Med       Date:  2019-12-19       Impact factor: 2.447

3.  Short interspersed DNA elements and miRNAs: a novel hidden gene regulation layer in zebrafish?

Authors:  Margherita Scarpato; Claudia Angelini; Ennio Cocca; Maria M Pallotta; Maria A Morescalchi; Teresa Capriglione
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

4.  MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2.

Authors:  Hai-Xia Liang; Yu-Hong Li
Journal:  Genes Genomics       Date:  2020-01-04       Impact factor: 1.839

5.  Silencing miRNA-1297 suppresses the invasion and migration of prostate cancer cells via targeting modulation of PTEN and blocking of the AKT/ERK pathway.

Authors:  Lei Wang; Jing Gao; Yu Zhang; Shaosan Kang
Journal:  Exp Ther Med       Date:  2021-05-17       Impact factor: 2.447

6.  Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.

Authors:  Anna Komina; Nadezhda Palkina; Mariya Aksenenko; Seseg Tsyrenzhapova; Tatiana Ruksha
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

7.  New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.

Authors:  Neil Johns; Cynthia Stretch; Benjamin H L Tan; Tora S Solheim; Sveinung Sørhaug; Nathan A Stephens; Ioannis Gioulbasanis; Richard J E Skipworth; D A Christopher Deans; Antonio Vigano; James A Ross; Oliver F Bathe; Michel L Tremblay; Stein Kaasa; Florian Strasser; Bruno Gagnon; Vickie E Baracos; Sambasivarao Damaraju; Kenneth C H Fearon
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-08-05       Impact factor: 12.910

8.  miR‑135a‑5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer.

Authors:  Haiyan Diao; Xing Xu; Bin Zhao; Guanghua Yang
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

Review 9.  Role of Exosomal MicroRNAs and myomiRs in the Development of Cancer Cachexia-Associated Muscle Wasting.

Authors:  Rodolfo Marinho; Paulo S M Alcântara; José P Ottoch; Marilia Seelaender
Journal:  Front Nutr       Date:  2018-01-09

10.  Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles.

Authors:  Xing Zhang; YuYan Sun; Peng Wang; Changfu Yang; Shengwei Li
Journal:  Onco Targets Ther       Date:  2017-06-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.